Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/25/20241:38AMPR Newswire (Canada)Wanhua Chemical Launches Barcelona R&D Center, Unveiling Signified Focus and Commitment in Europe and Beyond
04/25/20241:38AMPR Newswire (US)Wanhua Chemical Launches Barcelona R&D Center, Unveiling Signified Focus and Commitment in Europe and Beyond
04/25/20241:37AMAlliance NewsAlliance NewsGET READY: AstraZeneca, Barclays, J Sainsbury, Relx, Weir at 0700 BST
04/25/20241:37AMAlliance NewsAlliance NewsAlliance News UK - start of day
04/25/20241:32AMGlobeNewswire Inc.Crossject reports audited financial results for 2023EU:ALCJCrossject
04/25/20241:32AMGlobeNewswire Inc.Crossject communique ses résultats financiers audités pour 2023EU:ALCJCrossject
04/25/20241:32AMGlobeNewswire Inc.Crossject reports audited financial results for 2023EU:ALCJCrossject
04/25/20241:30AMGlobeNewswire Inc.Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidanceEU:SANSanofi
04/25/20241:30AMGlobeNewswire Inc.Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancementsEU:SANSanofi
04/25/20241:30AMGlobeNewswire Inc.Huhtamäki Oyj’s Interim Report January 1–March 31, 2024: Improved operational profitabilityTG:HUKIHuhtamaki Oyj
04/25/20241:30AMGlobeNewswire Inc.Atos reports first quarter 2024 performanceTG:AXIAtos SE
04/25/20241:30AMGlobeNewswire Inc.ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-DateEU:ONWDOnward Medical NV
04/25/20241:30AMGlobeNewswire Inc.Atos publie sa performance du premier trimestre 2024EU:ATOAtos SE
04/25/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
04/25/20241:30AMGlobeNewswire Inc.Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancementsBIT:1SANSanofi
04/25/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
04/25/20241:30AMGlobeNewswire Inc.Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidanceBIT:SANFSanofi
04/25/20241:30AMGlobeNewswire Inc.Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidanceTG:SNWSanofi
04/25/20241:30AMGlobeNewswire Inc.BUREAU VERITAS - Strong start to the year; 2024 outlook confirmedEU:BVIBureau Veritas
04/25/20241:30AMGlobeNewswire Inc.Flow Traders Q1 2024 Trading Update
04/25/20241:30AMGlobeNewswire Inc.Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidanceBIT:1SANSanofi
04/25/20241:30AMGlobeNewswire Inc.Atos publie sa performance du premier trimestre 2024TG:AXIAtos SE
04/25/20241:30AMGlobeNewswire Inc.Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancementsTG:SNWSanofi
04/25/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
04/25/20241:30AMGlobeNewswire Inc.Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancementsBIT:SANFSanofi
04/25/20241:30AMGlobeNewswire Inc.BUREAU VERITAS - Strong start to the year; 2024 outlook confirmedTG:4BVBureau Veritas
04/25/20241:30AMGlobeNewswire Inc.Atos reports first quarter 2024 performanceEU:ATOAtos SE
04/25/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
04/25/20241:30AMBusiness WirePERNOD RICARD: PERFORMANCE SOLIDE DU CHIFFRE D’AFFAIRES 9 MOIS, AMELIORATION DE LA DYNAMIQUE AU T3
04/25/20241:30AMBusiness WirePernod Ricard: Robust Performance With Improving Momentum in Q3